Gilead Stock Hits High Ahead Of Q4 Earnings Report
Shares of Gilead Sciences (GILD) hit an all-time high above 41 Friday as the biotech prepared to report Q4 and full-year earnings after the close Monday. The stock had slipped a bit and was trading near 40.65, up 3%, Friday afternoon. Analysts polled by Thomson Reuters expect a fairly slow quarter, with earnings down 2% from the year-ago quarter to 48 cents a share, and sales rising 10.6% to $2.43 billion. The report will provide some more clarity
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here